Elevance Health Inc. (NYSE: ELV) reported Q3 EPS of $8.37, $1.29 worse than the analyst estimate of $9.66. Revenue for the quarter came in at $44.7 billion versus the consensus estimate of $43.46 billion.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.